Genetic mutation analysis for dysgenetic (abnormal development) of the pancreas
This test checks for genetic changes that may affect how your pancreas develops, which could influence future health risks related to pancreatic function or disease.
["This test helps identify inherited conditions that might impact pancreatic development and long-term health risks."]
Key facts at a glance
- LOINC
- 32653-8
- Short code
- DYS gene Mut Anl Bld/T
- Synonyms
- DYS gene Mut Anl Bld/T
- Category
- chemistry
- Sample
- whole-blood
- Container
- Lavender-top (EDTA)
- Units
- N/A
- Fasting
- false
- Population
- adult
- Sex
- all
- Age range
- 18–65 years
- Method
- molgen
- Specimen volume
- 3 mL
- Stability
- Room temperature: 4h, Refrigerated: 24h
- Hemolysis max
- 0
- Lipemia max
- 0
- Icterus max
- 0
- TAT
- 4–24 hours
- Order
- routine
Why This Test Might Be Ordered
Your healthcare provider may recommend this test if you have a family history of pancreatic abnormalities, congenital conditions affecting organ development, or if you’re considering genetic counseling. It’s also used in prenatal or newborn screening for certain genetic syndromes.
What to Expect Before the Test
You’ll likely provide a blood sample (whole blood) collected by a healthcare professional. If testing is done during pregnancy, a blood draw or amniocentesis may be arranged. No special preparation is needed beyond standard lab procedures.
What the Test Results Mean
Results will indicate whether specific genetic mutations linked to pancreatic dysgenesis are present. Positive findings may guide further medical evaluation, including specialist referrals or monitoring for developmental or functional issues.
Common Conditions This Test Helps Diagnose
This test is primarily used to detect mutations associated with congenital pancreatic hypoplasia or aplasia (underdevelopment or absence of the pancreas), which can lead to conditions like cystic fibrosis, pancreatic insufficiency, or other metabolic disorders.
Clinical interpretation
How abnormal results are interpreted and what conditions they suggest.
Detecting these mutations helps identify individuals at higher risk for pancreatic-related complications early in life. Early diagnosis may allow for proactive management, such as dietary adjustments, enzyme supplements, or monitoring for symptoms like digestive issues or diabetes.
Short name
Pancreatic Development Mutation Screening
Frequently asked questions
Will this test show if I have diabetes later in life?
How long will I need to wait for results?
Yes, this test can be performed during pregnancy, often through a blood sample or prenatal screening. It’s important to discuss the risks and benefits with your obstetrician or genetic counselor before proceeding.
Sources
- 1
- 2Lab Tests OnlineSource
- 3
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy